Histological Findings of Carcinoid Tumors
Carcinoid tumors demonstrate highly organized neuroendocrine architecture with bland, uniform cytologic features including moderate granular cytoplasm, finely granular "salt and pepper" chromatin, low nuclear-to-cytoplasmic ratio, and round to ovoid nuclei with inconspicuous nucleoli. 1
Cytomorphologic Features
Typical carcinoids (TC) display the following cellular characteristics:
- Uniform, bland tumor cells with moderate amounts of eosinophilic, finely granular cytoplasm 1
- Round to ovoid nuclei with finely granular, evenly distributed "salt and pepper" chromatin pattern 1
- Inconspicuous or absent nucleoli, distinguishing them from large cell neuroendocrine carcinoma 1
- Low nuclear-to-cytoplasmic ratio, contrasting sharply with small cell lung cancer 1
- Minimal nuclear pleomorphism or atypia, though cell atypia alone does not reclassify the tumor 1
Architectural Patterns
The growth patterns are highly characteristic:
- Organoid nesting is the most common architectural pattern 1
- Trabecular (ribbon-like) arrangement of tumor cells 1
- Insular growth pattern with well-defined tumor cell islands 1
- Palisading pattern around blood vessels 1
- Rosette formation may be present 1
- Acinar or glandular profiles can occasionally be seen 2, 3
Mitotic Activity and Necrosis
The mitotic count is the single most critical histologic criterion for classification:
- Typical carcinoid: <2 mitoses per 2 mm² (or <2 per 10 HPF) with rare to absent mitotic figures 1
- Atypical carcinoid: 2-10 mitoses per 2 mm² with greater mitotic activity 1
- Mitoses should be counted in areas of highest activity, and when near cutoffs, at least three 2-mm² fields should be counted with the mean used for classification 1
Necrosis patterns differ significantly:
- Typical carcinoids typically lack necrosis 1
- Atypical carcinoids show punctate (focal, discrete) necrosis only 1
- Confluent or geographic necrosis indicates higher-grade neuroendocrine carcinoma, not carcinoid 1
Immunohistochemical Profile
Both typical and atypical carcinoids demonstrate strong neuroendocrine marker expression:
- Chromogranin A: positive in the majority of cases 1
- Synaptophysin: positive with strong, diffuse staining 1
- CD56/NCAM: positive in most cases 1
- TTF-1: positive in 85-90% of pulmonary carcinoids, though this does not confirm pulmonary origin as it's expressed in extrapulmonary sites 1
- Cytokeratin (AE1/AE3, CAM5.2): positive in nearly all cases 1
Proliferative Index
Ki-67 labeling index is particularly valuable in small biopsies:
- Typical and atypical carcinoids: Ki-67 index 5-15% (generally low) 1
- Small cell lung cancer: Ki-67 index 50-100% (markedly elevated) 1
- Ki-67 cannot reliably distinguish typical from atypical carcinoids but is useful for separating carcinoids from high-grade neuroendocrine carcinomas 1, 4
Distinguishing Features from Other Neuroendocrine Tumors
Critical differences from small cell lung cancer:
- Carcinoids have larger cells with more abundant cytoplasm versus SCLC's scant cytoplasm 1
- Carcinoids lack nuclear molding, a hallmark of SCLC 1
- Carcinoids show organized architecture rather than SCLC's sheet-like growth 1
- Crush artifact and Azzopardi effect (perivascular basophilic condensation) are absent in carcinoids but common in SCLC 1
Critical differences from large cell neuroendocrine carcinoma (LCNEC):
- LCNEC has >10 mitoses per 2 mm² with confluent necrosis 1
- LCNEC shows more cytologic atypia and larger cell size 1
- LCNEC demonstrates more aggressive architectural patterns with less organized structure 1
Special Histologic Variants and Associated Findings
Additional features that may be present:
- Argyrophilic granules can be demonstrated with special stains 5
- Mucin production may be present in some cases 5
- Spindle cell pattern, squamous metaplasia, or pleomorphism can rarely occur 2
- Association with diffuse idiopathic pulmonary neuroendocrine cell hyperplasia (DIPNECH), tumorlets, or multiple tumors suggests multiple primaries rather than metastases 1
Common Diagnostic Pitfalls
Critical caveats in diagnosis:
- Small biopsy samples cannot reliably distinguish typical from atypical carcinoids because adequate assessment of mitotic rate and necrosis requires surgical specimens 1
- Crush artifact in small biopsies can make accurate mitotic counting difficult, necessitating Ki-67 immunostaining 1, 4
- Tumors with carcinoid morphology but >10 mitoses per 2 mm² represent a diagnostic challenge and may behave more aggressively despite carcinoid-like appearance 3
- Combined tumors exist where carcinoid features coexist with adenocarcinoma or squamous cell carcinoma components 1